What You Should Know:
– Kalderos, the data infrastructure and analytics company behind the world’s first Drug Discount Management platform, has appointed Daryl Todd as its new Chief Strategy Officer.
– Todd, a seasoned legal professional with extensive experience in the life sciences industry, brings a unique combination of legal expertise and patient advocacy to the table.
Building on a Strong Legacy
Todd’s impressive career boasts senior regulatory attorney roles, with a deep understanding of compliance, commercial contracting, and regulatory law. Before joining Kalderos, he served as Assistant General Counsel at Johnson & Johnson, focusing on legal, compliance, and consumer cost issues. In this role, he played a pivotal role in:
- Creating patient-centric programs to improve medication access, including copay assistance, vouchers, and innovative free-product initiatives.
- Structuring collaborative arrangements with hospitals and other healthcare stakeholders.
A Passion for Patient Advocacy
Todd’s commitment extends beyond legal expertise. For over a decade, he served as a board member for both the Johnson & Johnson Foundation and the Johnson & Johnson Patient Assistance Foundation. As lead attorney for these organizations, he played a key role in developing programs that helped low-income patients afford their prescribed medications.
Prior to Johnson & Johnson, Todd held senior counsel positions at both Bristol-Myers Squibb, where he worked on hospital agreements and patient assistance programs, and McCarter & English, where he represented hospitals in legal matters. He holds a law degree from Rutgers Law School and a bachelor’s degree in American History from the University of Pennsylvania.
Shaping the Future of Drug Discount Management
At Kalderos, Todd will collaborate with CEO Angie Franks and the leadership team to propel the company’s growth and solidify its position as the leading provider of drug discount management solutions. A key focus will be on:
- Developing innovative strategies to address drug discount challenges
- Optimizing approaches to deliver maximum discount value to consumers
“Daryl’s experience with hospitals and drug manufacturers, besides his meaningful work with patients and doctors, gives us valuable insights into 340B, Medicaid, and commercial drug discount programs designed to lower the price of drugs for consumers,” said Franks. “His guidance and expertise also will inform product development and market strategies.”
